TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22220772

Group type: EXPERIMENTAL
Intervention: Full-mouth scaling and root planing (SRP) + Ornidazole (ORN)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Full-mouth scaling and root planing (SRP) + Placebo
Number of subjects: 58
Study: 20804443

Group type: EXPERIMENTAL
Intervention: Technosphere Insulin (TI), single 30-U dose
Number of subjects: 36
Study: 18754845

Group type: COMPARATOR
Intervention: Pre-HD folic acid (5 mg) administration
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intra-HD folic acid (5 mg) administration
Number of subjects: 10
Study: 16884988

Group type: EXPERIMENTAL
Intervention: Heparinized oxygenator with salvaged autologous blood
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonheparinized oxygenator with cardiotomy suction
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Heparinized oxygenator with cardiotomy suction
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonheparinized oxygenator with salvaged autologous blood
Number of subjects: 60
Study: 12876164

Group type: EXPERIMENTAL
Intervention: Long term antibiotics
Number of subjects: 859

Group type: COMPARATOR
Intervention: Surgical correction of reflux (VUR)
Number of subjects: 859

Group type: EXPERIMENTAL
Intervention: Combined treatment (surgery and antibiotics)
Number of subjects: 859

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis
Number of subjects: 859

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 859
Study: 11054512

Group type: EXPERIMENTAL
Intervention: Atrial overdrive pacing (base rate set at 10 bpm above average heart rate, mean 75 bpm)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Normal pacing (base rate set at 60 bpm)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Atrial overdrive pacing
Number of subjects: 27

Group type: COMPARATOR
Intervention: Normal pacing
Number of subjects: 27
Study: 8723461

Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 298

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 298
Study: 1342209

Group type: EXPERIMENTAL
Intervention: Nitrendipine plus ranitidine (300 mg, 150 mg twice a day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nitrendipine plus placebo
Number of subjects: 12
Study: 3859359

Group type: EXPERIMENTAL
Intervention: CRT + ITC (induction intrathecal chemotherapy and cranial irradiation plus maintenance ITC)
Number of subjects: 87

Group type: COMPARATOR
Intervention: CSpRT (induction intrathecal chemotherapy and craniospinal irradiation with no maintenance ITC)
Number of subjects: 87
Study: 29453300

Group type: EXPERIMENTAL
Intervention: SPRAT (school-based lifestyle education involving parents)
Number of subjects: 1120

Group type: COMPARATOR
Intervention: Usual school education (control)
Number of subjects: 1120
Study: 26824884

Group type: EXPERIMENTAL
Intervention: Once daily hydromorphone (HOD)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Twice daily hydromorphone (HTD)
Number of subjects: 37
Study: 24850606

Group type: EXPERIMENTAL
Intervention: rosuvastatin 20 mg
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: rosuvastatin 10 mg with UDCA
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: combined statinotherapy with UDCA
Number of subjects: 79

Group type: COMPARATOR
Intervention: not applicable
Number of subjects: 79
Study: 22552107

Group type: EXPERIMENTAL
Intervention: Foam-based NPWT system
Number of subjects: 11

Group type: COMPARATOR
Intervention: Gauze-based NPWT system
Number of subjects: 11
Study: 20669672

Group type: EXPERIMENTAL
Intervention: Tetramethylpyrazine (TMP) 240 mg/d added to conventional treatment for 10-14 days
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional treatment (Piperacillin, Levofloxacin, Ambroxol, Doxofylline)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (Group C) consisting of 18 healthy adults
Number of subjects: 35
Study: 18510632

Group type: EXPERIMENTAL
Intervention: Alemtuzumab induction followed by delayed tacrolimus monotherapy
Number of subjects: 131

Group type: COMPARATOR
Intervention: Tacrolimus in combination with mycophenolate mofetil and steroids
Number of subjects: 131
Study: 15787014

Group type: EXPERIMENTAL
Intervention: Shape-scale color maps
Number of subjects: 0

Group type: COMPARATOR
Intervention: Human observer performance without color maps
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Human observer performance with color maps
Number of subjects: 0
Study: 12859378

Group type: EXPERIMENTAL
Intervention: BTX-A plus NASHA
Number of subjects: 38

Group type: COMPARATOR
Intervention: NASHA alone
Number of subjects: 38
Study: 11013016

Group type: EXPERIMENTAL
Intervention: Hydroactive polyurethane dressing (Cutinova Thin)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dry-gauze dressing
Number of subjects: 60
Study: 8622603

Group type: EXPERIMENTAL
Intervention: IV glucose bolus
Number of subjects: 8
Study: 1478392

Group type: EXPERIMENTAL
Intervention: Aerobic training program (thrice weekly for 8 weeks, starting at 40% of maximal oxygen uptake)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 6715100

Group type: EXPERIMENTAL
Intervention: Racewalking
Number of subjects: 8

Group type: COMPARATOR
Intervention: Running
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Racewalking and Running at similar VO2
Number of subjects: 8
Study: 29246705

Group type: EXPERIMENTAL
Intervention: Web-based decision aid (DA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard websites (National Cancer Institute, American Cancer Society, Breastcancer.org)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard websites
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (DA and standard websites)
Number of subjects: 0
Study: 28811107

Group type: EXPERIMENTAL
Intervention: Intraoperative periarticular injection with added morphine (0.1 mg/kg)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Intraoperative periarticular injection without added morphine
Number of subjects: 53
Study: 25554555

Group type: EXPERIMENTAL
Intervention: 45º head-of-bed elevation
Number of subjects: 15

Group type: COMPARATOR
Intervention: 30º head-of-bed elevation
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Deeper sedation
Number of subjects: 15
Study: 23646866

Group type: EXPERIMENTAL
Intervention: Group Cognitive Behavioral Therapy (GCBT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Waiting list control group with educational booklet
Number of subjects: 62
Study: 21264478

Group type: EXPERIMENTAL
Intervention: Rapid TPAg
Number of subjects: 102

Group type: COMPARATOR
Intervention: UBT
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: EIA
Number of subjects: 102
Study: 18793574

Group type: EXPERIMENTAL
Intervention: CJC-1131 (1.5 - 20.5 microg/kg) in healthy subjects
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: CJC-1131 (1.5 - 12 microg/kg) in Type 2 diabetic patients
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo in healthy subjects
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo in Type 2 diabetic patients
Number of subjects: 48
Study: 16552507

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced ultrasonography (CEUS)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Baseline ultrasound (US)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Contrast-enhanced computed tomography (CT)
Number of subjects: 253
Study: 12590681

Group type: EXPERIMENTAL
Intervention: Automated, patient-interactive system
Number of subjects: 44

Group type: COMPARATOR
Intervention: Traditional, practitioner-operated, manual programming methods
Number of subjects: 44
Study: 11019764

Group type: EXPERIMENTAL
Intervention: Culturally-sensitive multicomponent intervention with one phone call
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Culturally-sensitive multicomponent intervention with four phone calls
Number of subjects: 14

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Culturally-sensitive multicomponent intervention (both one and four calls)
Number of subjects: 14
Study: 8844450

Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg three times a day for 16 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg three times a day
Number of subjects: 12
Study: 1614087

Group type: EXPERIMENTAL
Intervention: 0.1% dexamethasone and antibiotics (first trial)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Antibiotics without steroids (first trial)
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: 0.1% dexamethasone 4x daily (second trial)
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: 0.1% dexamethasone 4x daily for 5 days, then 1x daily (second trial)
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: 0.1% dexamethasone 1x daily (second trial)
Number of subjects: 321
Study: 6486665

Group type: EXPERIMENTAL
Intervention: Althesin
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: etomidate
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 50% nitrous oxide in oxygen with fentanyl (20 or 25 micrograms/kg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 22
Study: 30325583

Group type: EXPERIMENTAL
Intervention: Sarpogrelate 100-mg tablets under fasting conditions
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Sarpogrelate 100-mg tablets under fed conditions
Number of subjects: 73

Group type: COMPARATOR
Intervention: Food intake
Number of subjects: 73
Study: 29247820

Group type: EXPERIMENTAL
Intervention: Local anesthesia (various agents and techniques)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Different anesthetic techniques and drug subgroups
Number of subjects: 144
Study: 26429522

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg for 1 week
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 24446723

Group type: EXPERIMENTAL
Intervention: SRT2104 0.25g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SRT2104 0.5g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SRT2104 1.0g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SRT2104 2.0g
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23052890

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH) with an individual target range temperature between 34 and 35 °C administered for 24 hours
Number of subjects: 1500
Study: 19914974

Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitors (PPIs)
Number of subjects: 121

Group type: COMPARATOR
Intervention: H(2) antagonists
Number of subjects: 121
Study: 17391558

Group type: EXPERIMENTAL
Intervention: DHA-rich fish oil (6 g/d; about 2 g n-3 PUFA; 1.6 g DHA/d)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Regular exercise (walking 3 d/week for 45 min at 75% of maximum heart rate)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sunflower oil (6 g/d, placebo)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Combination of moderate exercise and fish-oil supplementation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Exercise and oil combination
Number of subjects: 50
Study: 15467102

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (20 g x d(-1) Cr + 140 g x d(-1) glucose polymer)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (responders with increased intramuscular Cr levels)
Number of subjects: 21
Study: 11270005

Group type: EXPERIMENTAL
Intervention: Propofol/Remifentanil
Number of subjects: 124

Group type: COMPARATOR
Intervention: Isoflurane/Fentanyl
Number of subjects: 124
Study: 9894716

Group type: EXPERIMENTAL
Intervention: HLA-identical sibling BM (group A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PBPC (group B)
Number of subjects: 40
Study: 8647141

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg once daily
Number of subjects: 575

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 575
Study: 2253907

Group type: EXPERIMENTAL
Intervention: Famotidine infusion after 10 mg bolus
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Famotidine infusion alone
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 535237

Group type: EXPERIMENTAL
Intervention: Hauser procedure
Number of subjects: 75

Group type: COMPARATOR
Intervention: Roux-Goldthwait procedure
Number of subjects: 75
Study: 31944250

Group type: EXPERIMENTAL
Intervention: Parent-administered exercise program (10 minutes twice a day for 3 weeks)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Parent-administered exercise program
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 153
Study: 30958348

Group type: EXPERIMENTAL
Intervention: 20 IU intranasal insulin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 40 IU intranasal insulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26795297

Group type: EXPERIMENTAL
Intervention: Live narrative stimuli
Number of subjects: 193

Group type: COMPARATOR
Intervention: Audio-recorded narrative stimuli
Number of subjects: 193
Study: 24393856

Group type: EXPERIMENTAL
Intervention: Colorectal cancer-specific peptide vaccines (RNF43, TOMM34) with uracil/tegafur (UFT) + Leucovorin (LV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Colorectal cancer-specific peptide vaccines (RNF43, TOMM34)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vaccines against multiple peptides (RNF43, TOMM34, FOXM1, MELK, HJURP, VEGFR1, VEGFR2)
Number of subjects: 0
Study: 21765371

Group type: EXPERIMENTAL
Intervention: Intravitreal diclofenac (500 μg/0.1 mL)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Intravitreal triamcinolone (4 mg/0.1 mL)
Number of subjects: 32
Study: 19095404

Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CsA)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CsA) + daunorubicin
Number of subjects: 65

Group type: COMPARATOR
Intervention: Daunorubicin only
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Verapamil + daunorubicin
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CsA) + verapamil + daunorubicin
Number of subjects: 65
Study: 16671073

Group type: EXPERIMENTAL
Intervention: Bilateral subthalamic nucleus deep brain stimulation (B‐STN DBS)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Medication
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Bilateral subthalamic nucleus deep brain stimulation (B‐STN DBS) plus medication
Number of subjects: 28
Study: 14557884

Group type: EXPERIMENTAL
Intervention: Judo wrestling
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cycloergometric exercise
Number of subjects: 10

Group type: COMPARATOR
Intervention: Judo wrestling and Cycloergometric exercise
Number of subjects: 10
Study: 11739970

Group type: EXPERIMENTAL
Intervention: MMP-9 levels
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: HT presence
Number of subjects: 39
Study: 9272101

Group type: EXPERIMENTAL
Intervention: hGH at a weekly dosage of 0.5 IU/kg
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: hGH at a weekly dosage of 1.0 IU/kg
Number of subjects: 362

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 362
Study: 8430283

Group type: EXPERIMENTAL
Intervention: Amalgam Liner
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Copalite
Number of subjects: 29

Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 29

Group type: COMPARATOR
Intervention: All groups (Amalgam Liner, Copalite, Untreated)
Number of subjects: 29
Study: 3894693

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (2,000 rad)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Radical cystectomy alone
Number of subjects: 92
Study: 31802059

Group type: EXPERIMENTAL
Intervention: EVOO therapy
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (MCI without therapy)
Number of subjects: 108
Study: 29624536

Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training (n = 19)
Number of subjects: 43

Group type: COMPARATOR
Intervention: No intervention (Control group, n = 24)
Number of subjects: 43
Study: 27101729

Group type: EXPERIMENTAL
Intervention: Sublobar resection alone
Number of subjects: 212

Group type: COMPARATOR
Intervention: Sublobar resection with brachytherapy
Number of subjects: 212
Study: 24401516

Group type: EXPERIMENTAL
Intervention: Cabs'Air Composite (Cousin Biotech France)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Ventralex Hernia Patch (Bard USA)
Number of subjects: 83
Study: 22157510

Group type: EXPERIMENTAL
Intervention: Standardized isopropanolic black cohosh extract (Remifemin)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 304
Study: 20846724

Group type: EXPERIMENTAL
Intervention: AcrySof Toric IOL
Number of subjects: 517

Group type: COMPARATOR
Intervention: AcrySof spherical control IOL
Number of subjects: 517
Study: 17469691

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 16173887

Group type: EXPERIMENTAL
Intervention: HIV/AIDS education intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham intervention (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Follow-up scores
Number of subjects: 0
Study: 12231575

Group type: EXPERIMENTAL
Intervention: AHA diet + simvastatin (20 mg daily)
Number of subjects: 63

Group type: COMPARATOR
Intervention: AHA diet + placebo
Number of subjects: 63
Study: 10090187

Group type: EXPERIMENTAL
Intervention: ACR improvement criteria
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: EULAR improvement criteria
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: ACR and EULAR with extensive joint counts
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: ACR and EULAR with reduced joint counts
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Overall assessment of improvement by investigator and patient
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Radiographic progression association
Number of subjects: 9
Study: 7581096

Group type: EXPERIMENTAL
Intervention: rhGM-CSF 250 micrograms/m2/day
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 1710162

Group type: EXPERIMENTAL
Intervention: Indoramin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 6893787

Group type: EXPERIMENTAL
Intervention: Lactose hydrolyzed milk
Number of subjects: 14

Group type: COMPARATOR
Intervention: Nonhydrolyzed milks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Taste panel assessment
Number of subjects: 14
Study: 31418121

Group type: EXPERIMENTAL
Intervention: 200 g rice with 4 g dried wakame
Number of subjects: 26

Group type: COMPARATOR
Intervention: 200 g rice
Number of subjects: 26
Study: 28317321

Group type: EXPERIMENTAL
Intervention: Filtered training group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unfiltered training group
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 25145870

Group type: EXPERIMENTAL
Intervention: Motivational intervention followed by self-regulatory intervention
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Self-regulatory intervention followed by motivational intervention
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Both interventions (received by all participants by Time 3)
Number of subjects: 205
Study: 24189173

Group type: EXPERIMENTAL
Intervention: Brief Sexual Risk Management (BSRM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Enhanced Sexual Risk Management (ESRM)
Number of subjects: 30
Study: 21329988

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20mg/day plus celecoxib 400mg/day (200mg BID)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fluoxetine 20mg/day plus placebo
Number of subjects: 50
Study: 18789466

Group type: EXPERIMENTAL
Intervention: Anti-Giardia and anthelminthic treatment
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Anti-Giardia treatment only
Number of subjects: 222

Group type: COMPARATOR
Intervention: Control
Number of subjects: 222
Study: 17721622

Group type: EXPERIMENTAL
Intervention: tinzaparin at 175 IU/kg, subcutaneous once daily, along with supportive care including morphine analgesia
Number of subjects: 253

Group type: COMPARATOR
Intervention: placebo and the same supportive care
Number of subjects: 253
Study: 15487811

Group type: EXPERIMENTAL
Intervention: Nisolone (test) tablets
Number of subjects: 18

Group type: COMPARATOR
Intervention: Delta‐Cortef (reference) tablets
Number of subjects: 18
Study: 11451307

Group type: EXPERIMENTAL
Intervention: Lateral pull test
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Patellar tilt test
Number of subjects: 107
Study: 9569193

Group type: EXPERIMENTAL
Intervention: Weight loss intervention (mean: 10 kg)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Heterozygotes (Arg/Gln353)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Genotype (Arg353 homozygotes vs. heterozygotes)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Weight loss (6 months)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Cross-sectional and longitudinal associations
Number of subjects: 98
Study: 7923797

Group type: EXPERIMENTAL
Intervention: Low dose transdermal estrogen (Estraderm TTS 25 micrograms) + oral progestogen (Duphaston 10 mg, 10 days every month) + daily exercise (walking for 1 hour)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Withdrawal from HRT after 6 months
Number of subjects: 33
Study: 3062225

Group type: EXPERIMENTAL
Intervention: 2 mg molsidomine
Number of subjects: 37

Group type: COMPARATOR
Intervention: 10 mg isosorbide dinitrate
Number of subjects: 37
Study: 31561399

Group type: EXPERIMENTAL
Intervention: Treadmill-induced slips (12m/s²) followed by a novel trip (16.8m/s²)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (single unannounced trip)
Number of subjects: 26
Study: 27453154

Group type: EXPERIMENTAL
Intervention: Standardized manometric biofeedback protocol
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Training and certification of interventionists
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Biofeedback software on a novel tablet computer platform
Number of subjects: 24
Study: 26147154

Group type: EXPERIMENTAL
Intervention: OBV/PTV/r (25 mg/150 mg/100 mg) for 12 weeks (group A)
Number of subjects: 363

Group type: COMPARATOR
Intervention: Placebo (group B)
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: OBV/PTV/r (group C)
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: OBV/PTV/r (overall)
Number of subjects: 363